Bioactive compounds in cranberries and their role in prevention of urinary tract infections

10.1056/NEJMcp030027

10.1016/S0924-8579(00)00350-2

10.1056/NEJM200310233491720

10.7326/0003-4819-135-1-200107030-00012

10.1001/archinte.1914.00070150122008

10.1016/S0140-6736(05)75468-4

10.1007/s003450050161

Lynch D. M., 2004, Cranberry for prevention of urinary tract infections, Am. Fam. Physician, 70, 2175

10.1086/386328

Jepson R. G. Mihaljevic L. Craig J. Cranberries for preventing urinary tract infections Cochrane Database Syst. Rev.2004 CD001321.

10.1001/jama.1994.03510340041031

10.1136/bmj.322.7302.1571

Klein M. Cranberry: Urinary tract infection and other conditions http://grants.nih.gov/grants/guide/rfa‐files/RFA‐AT‐03‐004.html 2003.

10.1001/jama.287.23.3077

Gupta K. Howell A. B. Stamm W. E. Wobbe C. L.et al. Inhibition ofE. coliadherence to bladder epithelial cells by human urine collected after ingestion of cranberry juice cocktail is dose dependent Infect. Dis. Soc. Am. Annual Meeting Boston 2004 432.

Stothers L., 2002, A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women, Can. J. Urol., 9, 1158

Howell A. B., 2006, Cranberry capsule ingestion and bacterial anti‐adhesion activity of urine, FASEB J., 20, LB454, 10.1096/fasebj.20.5.LB100-a

Walker E. B., 1997, Cranberry concentrate: UTI prophylaxis, J. Fam. Practice, 45, 167

10.1089/acm.2005.11.875

Howell A. B. Comparison of the ability of proanthocyanidins extracted from cranberries vs. other foods to prevent bacterial adherence associated with urinary tract infections Inter. Conf. Exped. Nutraceut. Funct. Foods2000 Houston TX.

10.1067/mda.2003.8

10.1093/infdis/143.3.325

10.1128/IAI.22.1.247-254.1978

10.1111/j.1574-6941.1980.tb01608.x

10.1097/00007611-198712000-00012

10.1016/S0928-8244(03)00228-1

10.1016/S0022-5347(17)50751-X

10.1128/AAC.33.1.92

10.1056/NEJM199105303242214

10.1139/cjm-45-8-691

10.1007/s00345-005-0045-z

Monroy‐Torres R., 2005, Does cranberry juice have bacteriostatic activity?, Rev. Invest. Clin., 57, 442

10.2146/ajhp050499

Jones G. W., 1981, The invasion of HeLa cells by Salmonella typhimurium, Reversible and irreversible bacterial attachment and the role of bacterial mobility, J. Gen. Microbiol., 127, 351

Magnusson K. E., 1982, Hydrophobic interaction‐a mechanism of bacterial binding, Scand. J. Infect. Dis. Suppl., 33, 32

10.1016/S0927-7765(00)00131-4

10.1002/bit.20675

10.1016/S0022-5347(01)63983-1

10.1056/NEJM199810083391516

10.1016/S0031-9422(99)00573-7

10.1021/np000128u

10.1080/10408390209351915

Gupta K. Chou M. Y. Howell A. Wobbe C.et al. Cranberry products inhibit adherence of uropathogenicEscherichia colito primary cultured bladder and vaginal epithelial cells J. Urol.2007 in press.

Cos P., 2003, Proanthocyanidins in health care: Current and new trends, Curr. Med. Chem., 10, 1345

10.1093/jn/134.3.613

10.1016/0031-9422(91)83426-L

10.1111/j.1469-8137.2004.01217.x

10.1016/0031-9422(73)80701-0

Hagerman A. E., 1981, The specificity of proanthocyanidin‐protein interactions, Biol. Chem., 256, 4494, 10.1016/S0021-9258(19)69462-7

Harborne J. B. (Ed.) The Flavonoids Chapman & Hall London 1994.

10.1021/jf034815d

10.1016/j.phytochem.2005.05.022

10.1021/jf020214v

10.1002/jsfa.2347

10.1021/bk-2004-0886.ch014

10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.0.CO;2-1

10.1093/ajcn/77.4.912

10.1007/BF03189365

Howell A. B., 2001, In vivo evidence that cranberry proanthocyanidins inhibit adherence of P‐fimbriated E. coli bacteria to uroepithelial cells, FASEB J., 15, A284

10.1007/BF00385059

10.1021/jf001211q

Cunningham D. G. Vannozzi S. O'Shea E. Turk R. Analysis and standardization of cranberry products in: Ho C. T. (Ed.) Quality Management of Nutraceuticals American Chemical Society Washington DC 2002 pp. 151–166.

10.1016/S0031-9422(03)00377-7

10.1021/jf980760h